Skip to main content
Toggle navigation
Login
Home
Favorite Icons
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Livestream
Multiple Session Occurrences
Special Event
Audience Response System
Ticketed Session
Presentado en Español
Closed Captioning
Scientific Program
Sold Out Ticketed Session
New & Evolving Topics
Traducción Español
Rx (Pharmacology)
Back
Favorite
Jan Marquard, MD
Executive Director in Clinical Development
Boehringer Ingelheim
AAP 2023 Abstract(s):
P4A043: Durable Improvement in Glycated Hemoglobin in Youth-onset Type 2 Diabetes: A Post Hoc Analysis of the DINAMO Trial of Empagliflozin and Linagliptin versus Placebo
Monday, October 23, 2023
11:00 AM – 12:00 PM
US EDT